Simple fluid drain may ease breathing in heart failure

NCT ID NCT07419360

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether removing fluid from around the lungs (a procedure called thoracentesis) can reduce shortness of breath in people hospitalized for heart failure. About 216 adults will either get standard heart failure medicines alone or medicines plus the fluid removal. Researchers will measure breathlessness and quality of life right after the procedure and again at 14 and 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
thoracentesis (fluid removal procedure)
What this could lead to
If it works, this could provide a simple, routine procedure to quickly relieve breathlessness in heart failure patients with fluid around the lungs.
What could go wrong
This is a relatively small, early-stage trial (216 participants) testing a short-term symptom benefit. The procedure carries small risks like bleeding or infection, and the improvement may be modest or not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGESTIVE HEART FAILURE(CHF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Albany Medical Center

    RECRUITING

    Albany, New York, 12211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.